Aptose Biosciences Inc. is a biotechnology company based in San Diego, CA, specializing in the development of innovative therapies for cancer treatment. With a strong management team and scientific advisory board, Aptose Biosciences is focused on advancing its product pipeline, which includes Tuspetinib for AML and Luxeptinib for B-cell and Myeloid tumors.
Driven by a commitment to scientific excellence and patient care, Aptose Biosciences conducts clinical trials for various indications, including CLL, NHL, and AML. The company's dedication to innovation and its mission to improve cancer treatment make it a key player in the biotech industry.
Generated from the website